Success Metrics

Clinical Success Rate

75.0%

Based on 6 completed trials

Completion Rate

75%(6/8)

Active Trials

0(0%)

Results Posted

117%(7 trials)

Terminated

2(22%)

Phase Distribution

Ph not_applicable

11%

Ph phase_4

78%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 4Post-market surveillance

7(87.5%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(3)

Detailed Status

Completed6

Terminated2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 47 (87.5%)

N/A1 (12.5%)

Trials by Status

completed667%

terminated222%

withdrawn111%

Recent Activity

0 active trials

Showing 5 of 9

terminatedphase_4

Clinical Trials (9)

Showing 9 of 9 trials

NCT02718625Phase 4

Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers

Terminated

NCT02250183Not Applicable

Medihoney and Santyl for Burn Injuries

Terminated

NCT02581488Phase 4

Use of Santyl in Diabetic Foot Ulcers

Completed

NCT02716519Phase 4

Use of Santyl Within an Accountable Care Organization

Withdrawn

NCT01408277Phase 4

Using Santyl on Diabetic Foot Ulcers

Completed

NCT01143727Phase 4

Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers

Completed

NCT01143714Phase 4

A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers

Completed

NCT01705860

Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation

Completed

NCT01056198Phase 4

Santyl vs. Sharp Debridement of Diabetic Foot Wounds

Completed

All 9 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 9